Norman Hardman Ph.D. is Director at Chelsea Therapeutics International, Ltd. (CHTP). They have made 1 open-market trade across 1 company since 2008, most recently 2008-10-03.
CIK 0001123617
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CHTP | 5,000 | — |
Shares reported on the most recent Form 4, priced at the 2008-10-07 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CHTP | BUY | 2008-10-03 | 2008-10-07 | $3.13 | $16K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.